Study: Synthetic THC Kills Leukemia Cells
Tubingen, Germany: The administration of FDA-approved synthetic THC (dronabinol) induces death in leukemia cell lines and offers a “low-toxic therapy option” for patients with cancer, according to findings published online in the journal BMC Cancer.
German researchers evaluated the impact of dronabinol on leukemia cells. Investigators reported that synthetic THC displayed “remarkable anti-proliferative as well as pro-apoptopic efficacy … in a broad spectrum of acute leukemia cell lines.” These findings “provide a promising rationale for the clinical use of cannabinoids … in distinct entities of acute leukemia,” they concluded.
Preclinical data dating back over four decades has consistently documented the… Continue reading